Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial.
about
Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.First qualification study of serum biomarkers as indicators of total body burden of osteoarthritisDisease-modifying osteoarthritis drugs: in vitro and in vivo data on the development of DMOADs under investigation.Effects of risedronate on osteoarthritis of the knee.Bone marrow lesions: a universal bone response to injury?Methodologic issues in clinical trials for prevention or risk reduction in osteoarthritisOrthopedic tissue regeneration: cells, scaffolds, and small molecules.Effect of antiresorptive and anabolic bone therapy on development of osteoarthritis in a posttraumatic rat model of OAApplication of biomarkers in the development of drugs intended for the treatment of osteoarthritisAcute Molecular Changes in Synovial Fluid Following Human Knee Injury: Association With Early Clinical Outcomes.Urinary CTX-II concentrations are elevated and associated with knee pain and function in subjects with ACL reconstruction.Analysis of microarchitectural changes in a mouse temporomandibular joint osteoarthritis model.Longitudinal changes of serum COMP and urinary CTX-II predict X-ray defined knee osteoarthritis severity and stiffness in women.Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development.Application of biochemical markers in development of drugs for treatment of osteoarthritis.Non-surgical management of early knee osteoarthritis.Animal models in OA: a means to explore bone.The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments?Altered Central Sensitization and Pain Modulation in the CNS in Chronic Joint Pain.Investigational drugs for the treatment of osteoarthritis.Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage-bone crosstalk.Beclin 1 overexpression inhibits chondrocyte apoptosis and downregulates extracellular matrix metabolism in osteoarthritis.No effect of risedronate on articular cartilage damage in the Dunkin Hartley guinea pig model of osteoarthritis.Alendronate treatment for hip osteoarthritis: prospective randomized 2-year trial.Predictive Validity of Radiographic Trabecular Bone Texture in Knee Osteoarthritis: The Osteoarthritis Research Society International/Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium.Isoliquiritigenin blunts osteoarthritis by inhibition of bone resorption and angiogenesis in subchondral bone.Osteoporotic changes of subchondral trabecular bone in osteoarthritis of the knee: a 3-T MRI study.The anatomical basis for a novel classification of osteoarthritis and allied disorders.
P2860
Q27687777-A071B652-0BB7-497D-B5AA-659AEB9AD310Q28748487-C21F7F9E-619B-41D2-90A7-C96D42E94643Q30588700-94BCD264-A69B-4413-BE19-5AB258161337Q33670485-336755EC-C640-4BD6-A6C0-4EE7DDD2BE16Q34013884-56303021-D4FA-4B97-B466-8F7E2EF75747Q35678484-B3F0C39E-15B6-4ED3-A145-C3C87BE8DA1AQ35857454-CF405634-D6EF-4621-93C1-E6ED478DA558Q36255352-08B3D1EF-4BA1-43FA-BF48-3DC83F11F187Q36598469-3C3FD26E-BCE8-47C8-A42B-EE84A95B965CQ37221990-0ABC6520-C954-4D75-AB7E-D3F26F398A88Q37426352-04E235ED-D299-4718-9C19-C1E4F7F021F6Q37455268-6379A158-0906-467E-9E33-AAD63F18048BQ37457066-69DDDCB0-41D7-4A67-9510-24BA3AAE70D7Q37462448-2120B77D-97F0-4F3A-8511-6DF959ED80F3Q37677789-46B68E02-FD80-48B3-A942-D995A2E545F3Q37950849-6A89F21B-401E-4CDA-B51A-D8800B7A1CDBQ38062380-20DD2FD4-5A5D-46B4-9ECB-1B7E400E7485Q38166991-BCDD7B69-D9BC-43F8-A310-E5CE010AC254Q38508821-72AD3BEB-E33F-450E-9B7C-2A1CA14FA73BQ38597565-0ADB0DD5-7773-4C05-92F0-6C2FE47DCFACQ38960505-5573ADDD-0C3A-4F5C-8F30-C6A8E8489C1DQ42679503-9A75BF89-03D0-4E48-96D7-4CAB263283EBQ44210916-182A8A72-79C6-4848-B4BD-82981540644AQ44343421-7425B7EA-BDDF-4D67-8593-18D32B5DB209Q46119442-AA849221-845A-4F3A-906A-3BEA41C02CBDQ48510720-DA577CDA-A420-454D-A1DE-AE7D75F633F6Q51498693-B3EF626F-F4BE-49DC-A617-27637B1F1B46Q52848337-A5027DE4-9A6F-475E-A4E9-93252A5DAEB1
P2860
Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Relationships between biochemi ...... tis randomized clinical trial.
@en
Relationships between biochemi ...... tis randomized clinical trial.
@en-gb
Relationships between biochemi ...... tis randomized clinical trial.
@nl
type
label
Relationships between biochemi ...... tis randomized clinical trial.
@en
Relationships between biochemi ...... tis randomized clinical trial.
@en-gb
Relationships between biochemi ...... tis randomized clinical trial.
@nl
prefLabel
Relationships between biochemi ...... tis randomized clinical trial.
@en
Relationships between biochemi ...... tis randomized clinical trial.
@en-gb
Relationships between biochemi ...... tis randomized clinical trial.
@nl
P2093
P1476
Relationships between biochemi ...... tis randomized clinical trial.
@en
P2093
C Christiansen
C O Bingham
W S Aronstein
P304
P356
10.1016/J.JOCA.2007.10.002
P577
2007-11-13T00:00:00Z